guanidine has been researched along with naloxone in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Callado, LF; Dardonville, C; Fernandez-Fernandez, C; Gabilondo, AM; Gibbons, SL; Jagerovic, N; Meana, JJ; Ryan, GJ | 1 |
1 review(s) available for guanidine and naloxone
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 other study(ies) available for guanidine and naloxone
| Article | Year |
|---|---|
Synthesis and pharmacological studies of new hybrid derivatives of fentanyl active at the mu-opioid receptor and I2-imidazoline binding sites.
Topics: Analgesics, Opioid; Animals; Binding Sites; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Fentanyl; Guanidine; Guanosine 5'-O-(3-Thiotriphosphate); Humans; Imidazoline Receptors; In Vitro Techniques; Indicators and Reagents; Male; Membranes; Mice; Naloxone; Narcotic Antagonists; Pain Measurement; Prefrontal Cortex; Reaction Time; Receptors, Drug; Receptors, Opioid, mu; Structure-Activity Relationship | 2006 |